This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (89)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Adverse Effects  • Coagulation Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Theodore E. Warkentin, MD; Robin S. Roberts, MSc; Jack Hirsh, MD; John G. Kelton, MD

Arch Intern Med. 2003;163:2518-2524.

Background  Diagnosis of immune heparin-induced thrombocytopenia (HIT) is usually based on a fall in platelet count below 150 x 10⁹/L (standard definition of thrombocytopenia). However, this definition may be inappropriate for postoperative patients who often develop postoperative thrombocytosis. We sought to determine an improved definition of thrombocytopenia indicating HIT in postoperative orthopedic patients, including its impact on frequency and thrombotic risk of HIT.

Methods  We performed a secondary analysis of a clinical trial of 665 patients who received unfractionated or low-molecular-weight heparin following elective hip arthroplasty. Daily platelet counts and objective studies for deep vein thrombosis were performed in all patients. Laboratory detection of HIT antibodies from a 362-patient subgroup was used to define sensitivity and specificity of various definitions of thrombocytopenia to indicate HIT.

Results  The improved definition of HIT was a 50% or greater platelet count fall from the postoperative peak, as this definition had greater sensitivity (50% vs 25%) and similar high specificity (99.1% vs 99.4%) for detecting HIT-IgG compared with the standard definition. Patients with HIT who were identified using the improved definition had a higher frequency of thrombosis than patients without HIT (72.2% vs 17.3%; P<.001). The improved definition showed an even greater absolute difference in frequency of HIT between unfractionated and low-molecular-weight heparin (4.8% vs 0.6%; P<.001) compared with the standard definition (2.7% vs 0%; P = .002).

Conclusion  A 50% or greater fall in the platelet count from the postoperative peak is a sensitive definition indicating possible HIT that is associated with an increased risk of thrombosis.

From McMaster University (Drs Warkentin, Hirsh, and Kelton and Mr Roberts), the Henderson Research Centre (Dr Hirsh and Prof Roberts), and the Hamilton Regional Laboratory Medicine Program (Dr Warkentin), Hamilton, Ontario. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Improving the Definition of Heparin-Induced Thrombocytopenia
Lorenz Risch and Andreas R. Huber
Arch Intern Med. 2004;164(15):1699.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Compliance with Platelet Count Monitoring Recommendations and Management of Possible Heparin-Induced Thrombocytopenia in Hospitalized Patients Receiving Low-Molecular-Weight Heparin
ten Berg et al.
The Annals of Pharmacotherapy 2009;43:1405-1412.
ABSTRACT | FULL TEXT  

Heparin-Induced Thrombocytopenia: A Contemporary Clinical Approach to Diagnosis and Management
Shantsila et al.
Chest 2009;135:1651-1664.
ABSTRACT | FULL TEXT  

Studies of the immune response in heparin-induced thrombocytopenia
Warkentin et al.
Blood 2009;113:4963-4969.
ABSTRACT | FULL TEXT  

Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?
Warkentin et al.
Ann. Thorac. Surg. 2009;87:1633-1640.
ABSTRACT | FULL TEXT  

Heparin-induced thrombocytopenia: a historical perspective
Kelton and Warkentin
Blood 2008;112:2607-2616.
FULL TEXT  

So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not?
Warkentin and Greinacher
Chest 2007;132:1108-1110.
FULL TEXT  

Prophylaxis for Thromboembolism in Hospitalized Medical Patients
Calderon-Gerstein et al.
NEJM 2007;357:304-306.
FULL TEXT  

Pulmonary Embolism in the Critically Ill
Carlbom and Davidson
Chest 2007;132:313-324.
ABSTRACT | FULL TEXT  

Who Is (Still) Getting HIT?
Warkentin and Eikelboom
Chest 2007;131:1620-1622.
FULL TEXT  

Platelet Count Decline: An Early Prognostic Marker in Critically Ill Patients With Prolonged ICU Stays
Moreau et al.
Chest 2007;131:1735-1741.
ABSTRACT | FULL TEXT  

Twice vs Three Times Daily Heparin Dosing for Thromboembolism Prophylaxis in the General Medical Population: A Metaanalysis
King et al.
Chest 2007;131:507-516.
ABSTRACT | FULL TEXT  

When is HIT Really HIT?
Warkentin and Crowther
Ann. Thorac. Surg. 2007;83:21-23.
FULL TEXT  

Heparin-induced thrombocytopenia: advances in diagnosis and treatment.
Cooney
Crit Care Nurse 2006;26:30-36.
FULL TEXT  

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia
Warkentin et al.
Blood 2006;108:2937-2941.
ABSTRACT | FULL TEXT  

Think of HIT When Thrombosis Follows Heparin.
Warkentin
Chest 2006;130:631-632.
FULL TEXT  

How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?
Levine et al.
Chest 2006;130:681-687.
ABSTRACT | FULL TEXT  

Heparin-Induced Thrombocytopenia
Arepally and Ortel
NEJM 2006;355:809-817.
FULL TEXT  

Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support
Schenk et al.
J. Thorac. Cardiovasc. Surg. 2006;131:1373-1381.
ABSTRACT | FULL TEXT  

Thrombocytopenia and Intra-cerebral Complications Associated with Low-Molecular-Weight Heparin Treatment in Patients Undergoing Total Hip Replacement. A Report of Two Cases
Lilikakis et al.
JBJS 2006;88:634-638.
FULL TEXT  

Heparin-induced thrombocytopenia: A COMPLICATION OF THROMBOPROPHYLAXIS
Kejariwal
J Bone Joint Surg Br 2006;88-B:392-393.
ABSTRACT | FULL TEXT  

Think of HIT
Warkentin
ASH Education Book 2006;2006:408-414.
ABSTRACT | FULL TEXT  

Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
Warkentin et al.
Blood 2005;106:3791-3796.
ABSTRACT | FULL TEXT  

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
Martel et al.
Blood 2005;106:2710-2715.
ABSTRACT | FULL TEXT  

How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults-1
Daneschvar and Daw
Mayo Clin Proc. 2005;80:1389-1389.
 

How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults-Reply-I
Tefferi
Mayo Clin Proc. 2005;80:1390-1392.
 

When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia
Jang and Hursting
Circulation 2005;111:2671-2683.
FULL TEXT  

Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome: A Nested Cohort Study
Warkentin et al.
Chest 2005;127:1857-1861.
ABSTRACT | FULL TEXT  

New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia
Warkentin
Chest 2005;127:35S-45S.
ABSTRACT | FULL TEXT  

Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.
Warkentin et al.
ASH ANNUAL MEETING ABSTRACTS 2004;104:3022-3022.
ABSTRACT  

Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Warkentin and Greinacher
Chest 2004;126:311S-337S.
ABSTRACT | FULL TEXT  

Improving the Definition of Heparin-Induced Thrombocytopenia
Risch and Huber
Arch Intern Med 2004;164:1699-1699.
FULL TEXT